Astute Medical, Inc., a San Diego, California-based company that is dedicated to identifying and validating protein biomarkers that can serve as the basis for novel diagnostic tests, completed a $13m financing.
The transaction, which represents an extension of the Series B round completed in May 2010, involved the sale of additional Series B shares to existing stockholders including Domain Associates, Delphi Ventures, De Novo Ventures and Johnson & Johnson Development Corporation.
Astute Medical intends to use the funds to advance and expand its research, development and validation of biomarker-based laboratory tests.
The company’s focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis.